Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

American Journal of Pathology

Volumn 161, Issue 6, 2002, Pages 1991-1996

  Van de Rijn, Matt ^a   Perou, Charles M ^c   Tibshirani, Rob ^b   Haas, Phillippe ^c   Kallioniemi, Olli ^e   Kononen, Juha ^f   Torhorst, Joachim ^d   Sauter, Guido ^d   Zuber, Markus ^g   Köchli, Ossi R ^h   Mross, Frank ⁱ   Dieterich, Holger ^j   Seitz, Rob ^k   Ross, Doug ^k   Botstein, David ^b   Brown, Pat ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f Diomeda Life Sciences Inc   (United States)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

ⁱ Kreiskrankenhaus   (Germany)

^j Frauenklinik   (Germany)

^k Applied Genomics Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN 15; CYTOKERATIN 5; MESSENGER RNA; MONOCLONAL ANTIBODY; PARAFFIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER SIZE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL;

EID: 0036899446     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64476-8     Document Type: Article

References (17)

1. Henson DE, Fielding LP, Grignon DJ, Page DL, Hammond ME, Nash G, Pettigrew NM, Gorstein F, Hutter RV: College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors: Summary Members of the Cancer Committee. Arch Pathol Lab Med 1995, 119:1109-1112
2. Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-168
3. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996, 14:1675-1680
4. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, Winkler J, Lockhart DJ, Morris MS, Fodor SP: Accessing genetic information with high-density DNA arrays. Science 1996, 274:610-614
5. Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G: Making and reading microarrays. Nat Genet 1999, 21:15-19
6. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Eisen MB, van de Rijn M, Jeffrey SS, Quist H, Rees CA, Brown PO, Botstein D, Lønning PE, Børresen-Dale A-L: Gene expression patterns of breast carcinomas distinguish tumor subclasses with potential clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874
7. Bucher C, Torhorst J, Kononen J, Haas P, Schraml L, Bubendorf L, Zuber M, Kochli OR, Mross F, Dieterich H, Askaa J, Godtfredsen SE, Seelig S, Moch H, Mihatsch M, Kallioniemi O, Sauter G: Prognostic significance of HER-2 amplification and overexpression in breast cancer: Methodological comparison of fluorescence in situ hybridization and immunohistochemistry using tissue microarrays of 611 primary breast cancers. J Pathol, in press
8. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi O, Sauter G: Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001, 159:2249-2256
9. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410
10. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847
11. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G: Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999, 5:1966-1975
12. Natkunam Y, Warnke RA, Montgomery K, Falini M, van de Rijn M: Analysis of MUM1/RF4-protein expression utilizing tissue microarrays and immunohistochemistry. Mod Pathol 2001, 7:686-694
13. Cox DR: Regression models and life tables. J R Stat Soc 1972, 74:187-220
14. Hoch RV, Thompson DA, Baker RJ, Weigel RJ: GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 1999, 84:122-128
15. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale A-L, Brown PO, Botstein D: Molecular portraits of human breast tumors. Nature 2000, 406:747-752
16. Dairkee SH, Mayall BH, Smith HS, Hackett AJ: Monoclonal marker that predicts early recurrence of breast cancer. Lancet 1987, 1:514
17. Malzahn K, Mitze M, Thoenes M, Moll R: Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas. Virchows Arch 1998, 433:119-129